Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22(+) B-acute lymphoblastic leukemia patients: a phase II study

Por Chevallier, Patrice, Huguet, Francoise, Raffoux, Emmanuel, Etienne, Anne, Leguay, Thibaut, Isnard, Francoise, Robillard, Nelly, Guillaume, Thierry, Delaunay, Jacques, Charbonnier, Aude, Pigneux, Arnaud, Peterlin, Pierre, Bené, Marie C., Wegener, William A., Goldenberg, David M., Dombret, Hervé
Publicado no Haematologica (2015)

Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia

Por Peterlin, Pierre, Renneville, Aline, Ben Abdelali, Raouf, Nibourel, Olivier, Thomas, Xavier, Pautas, Cécile, de Botton, Stéphane, Raffoux, Emmanuel, Cayuela, Jean-Michel, Boissel, Nicolas, Terré, Christine, Celli-Lebras, Karine, Castaigne, Sylvie, Preudhomme, Claude, Gardin, Claude, Dombret, Hervé
Publicado no Haematologica (2015)

Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia

Por Mohty, Mohamad, Malard, Florent, Blaise, Didier, Milpied, Noel, Socié, Gérard, Huynh, Anne, Reman, Oumédaly, Yakoub-Agha, Ibrahim, Furst, Sabine, Guillaume, Thierry, Tabrizi, Resa, Vigouroux, Stéphane, Peterlin, Pierre, El-Cheikh, Jean, Moreau, Philippe, Labopin, Myriam, Chevallier, Patrice
Publicado no Haematologica (2017)